Takashi Yabana

Learn More
Trastuzumab has recently been introduced as a treatment for HER2-positive metastatic and/or unresectable gastric cancer (MUGC); however, compared with breast cancer, some issues concerning HER2 and trastuzumab therapy for gastric cancer remain unclear. A 74-year-old woman received trastuzumab-containing chemotherapy for HER2-positive MUGC. She had a marked(More)
A 77-year-old man was admitted for abdominal pain. He had no anemia or abnormal physical findings. We diagnosed the patient with chololithic pancreatitis, and performed en-doscopic retrograde cholangiopancreatography. We began to insert a side-viewing duodenoscope, but had difficulty passing it through the left pyriform sinus. When we switched to a(More)
The patient was a 57-year-old man who was diagnosed with multiple lung metastases of sigmoid colon cancer. The patient developed progressive disease after 8 courses of bevacizumab + capecitabine and oxaliplatin therapy, therefore, bevacizumab + irinotecan, leucovorin, and 5-fluorouracil therapy was started. During the fifth course, he experienced pain on(More)
  • 1